Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.
Loading...
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Nilotinib, Skeletal muscle, Differentiation, Myoblasts, Proliferation, Tyrosine kinase inhibitors, p38 MAPK, ERK1/2, AKT